Literature DB >> 33290729

Handgrip Weakness and Asymmetry Independently Predict the Development of New Activity Limitations: Results from Analyses of Longitudinal Data from the US Health and Retirement Study.

Kelly Parker1, Yeong Rhee1, Grant R Tomkinson2, Brenda M Vincent3, Melissa L O'Connor4, Ryan McGrath5.   

Abstract

OBJECTIVES: Examining strength asymmetries in assessments of muscle function may improve screenings for limitations in independent living tasks such as instrumental activities of daily living (IADL). We sought to determine the associations between handgrip strength (HGS) asymmetry and future IADL limitations in aging Americans.
DESIGN: Longitudinal panel. SETTING AND PARTICIPANTS: Secondary analyses of data from participants aged at least 50 years from the 2006-2016 waves of the Health and Retirement Study. The analytic sample included 18,235 Americans who identified hand dominance and had measures of HGS for both hands in a single wave.
METHODS: Hand dominance was self-reported, and a handgrip dynamometer measured HGS on each hand. The highest HGS values on each hand were used to calculate the HGS asymmetry ratio: (nondominant HGS/dominant HGS). Individuals with HGS asymmetry ratio <0.80 or >1.20 had HGS asymmetry. Persons with HGS asymmetry ratio <0.80 had dominant HGS asymmetry, whereas participants with HGS asymmetry ratio >1.20 had nondominant HGS asymmetry. Persons with HGS asymmetry ratio <1.0 also had their ratio inversed to make all HGS asymmetry ratios ≥1.0. IADL were self-reported. Covariate-adjusted generalized estimating equations were used for the analyses.
RESULTS: Participants with HGS asymmetry had 1.12 [95% confidence interval (CI): 1.03-1.20] greater odds for future IADL limitations. Each HGS asymmetry dominance group also had greater odds for future IADL limitations: 1.09 (CI: 1.01-1.18) for individuals with dominant HGS asymmetry and 1.29 (CI: 1.09-1.52) for persons with nondominant HGS asymmetry. Every 0.10 increase in inverted HGS asymmetry ratio was associated with 1.30 (CI: 1.07-1.57) greater odds for future IADL limitations. CONCLUSIONS AND IMPLICATIONS: Assessing HGS asymmetry, as another potential biomarker of impaired muscle function, may provide novel insights for predicting IADL limitations. Future research should continue examining how strength asymmetries, and other aspects of muscle function beyond maximal strength, factor into the disabling cascade.
Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive dysfunction; geriatric assessment; independent living; muscle strength dynamometer; muscle weakness

Year:  2020        PMID: 33290729     DOI: 10.1016/j.jamda.2020.11.006

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  4 in total

1.  [Assessment of mobility/motor skills in old age : Based on the S1 guideline "Geriatric assessment level 2, living guideline"].

Authors:  S Krupp; E Freiberger; C Renner; W Hofmann
Journal:  Z Gerontol Geriatr       Date:  2022-04-20       Impact factor: 1.281

2.  Assessing Additional Characteristics of Muscle Function With Digital Handgrip Dynamometry and Accelerometry: Framework for a Novel Handgrip Strength Protocol.

Authors:  Ryan McGrath; Grant R Tomkinson; Brian C Clark; Peggy M Cawthon; Matteo Cesari; Soham Al Snih; Donald A Jurivich; Kyle J Hackney
Journal:  J Am Med Dir Assoc       Date:  2021-06-21       Impact factor: 4.669

3.  The estimated prevalence of no reported dementia-related diagnosis in older Americans living with possible dementia by healthcare utilization.

Authors:  Kelly Parker; Brenda Vincent; Yeong Rhee; Bong-Jin Choi; Sheria G Robinson-Lane; Jeremy M Hamm; Lukus Klawitter; Donald A Jurivich; Ryan McGrath
Journal:  Aging Clin Exp Res       Date:  2021-09-15       Impact factor: 3.636

4.  Handgrip strength asymmetry is associated with the risk of neurodegenerative disorders among Chinese older adults.

Authors:  Zi Chen; Mandy Ho; Pui Hing Chau
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-17       Impact factor: 12.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.